Metabolic Syndrome Traits Amplify Risk for Major Adverse Liver Outcomes in Type 2 Diabetes Patients

19 Mar 2024 • Research examining over 230,000 T2D patients without prior liver disease history has revealed a significant correlation: the accumulation of metabolic syndrome (MetS) traits heightened the risk of progression to major adverse liver outcomes (MALOs).

  • MetS traits included hypertension, low HDL level, hypertriglyceridemia, obesity, and albuminuria, in addition to T2D
  • Compared with patients with one MetS trait (only T2D) at baseline, those with more than one MetS trait had a higher rate of MALOs.
  • Specifically, each additional MetS trait increased the risk of MALOs by 1.28 times.
  • Hypertension stood out as a key contributor, with an adjusted hazard ratio of 2.06.

Source: Diabetes Care | Read full story

Contact us

+91 9023-729662

Medflix Logo

© 2022 Plexus Professionals Network Pvt Ltd